Drug
Methylene Blue
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Serotonin Syndrome | 469 | 340.1 | 487.2 | signal |
| 2 | Blood Potassium Increased | 62 | 51.9 | 54.0 | signal |
| 3 | Blood Lactate Dehydrogenase Increased | 60 | 51.1 | 53.1 | signal |
| 4 | Cardiogenic Shock | 51 | 48.5 | 50.1 | signal |
| 5 | Encephalopathy | 82 | 45.4 | 47.9 | signal |
| 6 | Mydriasis | 41 | 43.4 | 44.6 | signal |
| 7 | Shock | 64 | 38.0 | 39.6 | signal |
| 8 | Blood Creatine Phosphokinase Increased | 72 | 33.4 | 35.0 | signal |
| 9 | Muscle Rigidity | 28 | 31.8 | 32.3 | signal |
| 10 | Drug Interaction | 358 | 30.6 | 39.5 | signal |
| 11 | Lactic Acidosis | 60 | 25.3 | 26.3 | signal |
| 12 | Ileus | 22 | 24.2 | 24.6 | signal |
| 13 | Multiple Organ Dysfunction Syndrome | 46 | 22.3 | 23.0 | signal |
| 14 | Intentional Overdose | 100 | 21.3 | 22.6 | signal |
| 15 | Metabolic Acidosis | 49 | 21.0 | 21.6 | signal |
| 16 | Chromaturia | 33 | 19.8 | 20.2 | signal |
| 17 | Respiratory Depression | 17 | 18.8 | 19.0 | signal |
| 18 | Circulatory Collapse | 21 | 16.6 | 16.8 | signal |
| 19 | Coma | 58 | 16.5 | 17.1 | signal |
| 20 | Bradycardia | 62 | 15.8 | 16.4 | signal |
| 21 | Alanine Aminotransferase Increased | 67 | 14.8 | 15.4 | signal |
| 22 | Hypotension | 207 | 14.0 | 16.0 | signal |
| 23 | Myoclonus | 12 | 13.6 | 13.7 | signal |
| 24 | Depressed Level Of Consciousness | 39 | 13.4 | 13.7 | signal |
| 25 | Hypothermia | 10 | 13.3 | 13.4 | signal |
| 26 | Rhabdomyolysis | 41 | 13.3 | 13.7 | signal |
| 27 | Generalised Tonic-clonic Seizure | 16 | 13.2 | 13.4 | signal |
| 28 | Mental Status Changes | 27 | 13.2 | 13.4 | signal |
| 29 | Drug Ineffective For Unapproved Indication | 52 | 12.6 | 13.0 | signal |
| 30 | Acute Respiratory Distress Syndrome | 15 | 11.5 | 11.6 | signal |
| 31 | Toxicity To Various Agents | 140 | 11.3 | 12.3 | signal |
| 32 | Hyperkalaemia | 29 | 11.2 | 11.4 | signal |
| 33 | Agitation | 61 | 11.2 | 11.6 | signal |
| 34 | Neurotoxicity | 14 | 10.9 | 11.0 | signal |
| 35 | Brain Injury | 8 | 10.8 | 10.8 | signal |
| 36 | Sinus Tachycardia | 11 | 10.5 | 10.6 | signal |
| 37 | Delirium | 26 | 10.2 | 10.3 | signal |
| 38 | Leukocytosis | 13 | 9.7 | 9.8 | signal |
| 39 | Cardiac Arrest | 59 | 9.6 | 10.0 | signal |
| 40 | Post Procedural Complication | 13 | 9.1 | 9.2 | signal |
| 41 | Hypoxia | 23 | 8.9 | 9.0 | signal |
| 42 | Drug Toxicity | 9 | 8.8 | 8.9 | signal |
| 43 | Nephropathy Toxic | 7 | 8.5 | 8.5 | signal |
| 44 | Unresponsive To Stimuli | 16 | 8.4 | 8.5 | signal |
| 45 | Aphasia | 18 | 8.0 | 8.1 | signal |
| 46 | Dyskinesia | 23 | 7.7 | 7.8 | signal |
| 47 | Suicide Attempt | 33 | 7.4 | 7.5 | signal |
| 48 | Autoimmune Disorder | 5 | 7.1 | 7.1 | signal |
| 49 | Muscle Twitching | 12 | 7.0 | 7.1 | signal |
| 50 | Disorientation | 20 | 6.8 | 6.9 | signal |
| 51 | Overdose | 106 | 6.6 | 7.0 | signal |
| 52 | Paralysis | 7 | 6.6 | 6.6 | signal |
| 53 | Skin Discolouration | 22 | 6.5 | 6.6 | signal |
| 54 | Anaphylactic Reaction | 26 | 6.4 | 6.5 | signal |
| 55 | Anaphylactic Shock | 12 | 6.3 | 6.4 | signal |
| 56 | Psychomotor Hyperactivity | 7 | 5.7 | 5.7 | signal |
| 57 | Eosinophilia | 7 | 5.4 | 5.4 | signal |
| 58 | Poisoning | 5 | 5.4 | 5.4 | signal |
| 59 | Status Epilepticus | 4 | 4.8 | 4.8 | signal |
| 60 | Grand Mal Convulsion | 3 | 4.3 | 4.3 | signal |
| 61 | Intentional Self-injury | 6 | 4.0 | 4.0 | signal |
| 62 | Akathisia | 3 | 3.0 | 3.0 | no signal |
| 63 | Premature Delivery | 3 | 2.5 | 2.5 | no signal |
| 64 | Drug Effective For Unapproved Indication | 5 | 2.3 | 2.3 | no signal |
| 65 | Extrapyramidal Disorder | 4 | 2.2 | 2.2 | no signal |
| 66 | Completed Suicide | 10 | 1.6 | 1.6 | no signal |